Tomasoni D, Fonarow GC, Adamo M, Anker SD, et al. Sodium-glucose co-transporter 2 inhibitors as an early, first line therapy in patients with heart failure and reduced ejection fraction. Eur J Heart Fail 2021 Dec 10. doi: 10.1002/ejhf.2397.
PMID: 34894038